Amgen Q1 Adjusted EPS $4.90 Vs IBES Estimate $4.30
View all comments(0)
May 1 (Reuters) - Amgen Inc AMGN.O:
AMGEN Q1 ADJUSTED EPS $4.90 VERSUS IBES ESTIMATE $4.30
AMGEN Q1 TOTAL REVENUE $8.15 BILLION VERSUS IBES ESTIMATE $8.06 BILLION
AMGEN OUTLOOK FY TOTAL REVENUE $34.3 BILLION TO $35.7 BILLION VERSUS IBES ESTIMATE $35.09 BILLION
AMGEN: 2025 SHARE REPURCHASES NOT TO EXCEED $500 MILLION
AMGEN: 2025 OUTLOOK INCLUDES ESTIMATED IMPACT OF IMPLEMENTED TARIFFS, BUT DOES NOT ACCOUNT FOR ANY FUTURE LEVIES
AMGEN OUTLOOK FY ADJUSTED EPS $20.00 TO $21.20 VERSUS IBES ESTIMATE $20.64
AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING PEOPLE LIVING WITH OBESITY AFTER REMOVAL OF CLINICAL HOLD BY U.S. FDA
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Tradingkey





Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.